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• Infection outcome in mosquito
increases with Plasmodium
falciparum gametocyte density.
• At high Plasmodium berghei
gametocyte densities, infection
outcome in mosquito decreases.
• Reduction of infection intensity by
mAb 13.1 was constant over oocyst
intensities.
• Reduction of infection prevalence
by mAb 13.1 decreases at high
infection loads.
• Evaluation of TRIs should report
reduction of infection intensity
and prevalence.
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A B S T R A C T
The evaluation of transmission reducing interventions (TRI) to control malaria widely uses membrane
feeding assays. In such assays, the intensity of Plasmodium infection in the vector might affect the mea-
sured eﬃcacy of the candidates to block transmission. Gametocyte density in the host blood is a determinant
of the infection success in the mosquito, however, uncertain estimates of parasite densities and intrin-
sic characteristics of the infected blood can induce variability. To reduce this variation, a feasible method
is to dilute infectious blood samples. We describe the effect of diluting samples of Plasmodium-
containing blood samples to allow accurate relative measures of gametocyte densities and their impact
on mosquito infectivity and TRI eﬃcacy. Natural Plasmodium falciparum samples were diluted to gener-
ate a wide range of parasite densities, and fed to Anopheles coluzzii mosquitoes. This was compared with
parallel dilutions conducted on Plasmodium berghei infections. We examined how blood dilution inﬂu-
ences the observed blocking activity of anti-Pbs28 monoclonal antibody using the P. berghei/Anopheles
stephensi system.
In the natural species combination P. falciparum/An. coluzzii, blood dilution using heat-inactivated,
infected blood as diluents, revealed positive near linear relationships, between gametocyte densities and
oocyst loads in the range tested. A similar relationship was observed in the P. berghei/An. stephensi system
when using a similar dilution method. In contrast, diluting infected mice blood with fresh uninfected
blood dramatically increases the infectiousness. This suggests that highly infected mice blood contains
inhibitory factors or reduced blood moieties, which impede infection and may in turn, lead to misinter-
pretation when comparing individual TRI evaluation assays. In the lab system, the transmission blocking
activity of an antibody speciﬁc for Pbs28 was conﬁrmed to be density-dependent. This highlights the
need to carefully interpret evaluations of TRI candidates, regarding gametocyte densities in the P. berghei/
An. stephensi system.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The transmission of malaria requires the survival and develop-
ment of Plasmodiumwithin two individual organisms: the vertebrate
host and the mosquito vector. Female anopheline mosquitoes ingest
gametocytes when taking a blood meal from infectious vertebrate
hosts. Within the mosquito’s midgut, the parasite has to over-
come a strong population bottleneck; due to the low eﬃciency of
gamete fertilization (Alavi et al., 2003; Gouagna et al., 1998; Vaughan,
2007), and the pressure of both the vertebrate host immunity, still
acting in the bloodmeal (Bousema et al., 2011; Gouagna et al., 2004),
and the vector’s innate defense mechanisms (Blandin and Levashina,
2004; Yassine and Osta, 2010). For this reason, and the limited an-
tigenic variation exhibited by extracellular proteins expressed in the
sexual stages of parasite development (Kaslow et al., 1989; Manske
et al., 2012; Shi et al., 1992), the mosquito-stages of the parasite
life cycle are logical and attractive targets for transmission reduc-
ing interventions (TRIs) (Sinden, 2010). Since the reemergence of
the concept of transmission blocking of Plasmodium decades ago
(Carter and Chen, 1976; Gwadz, 1976; Huff et al., 1958), research
efforts have increased in an attempt to ﬁnd vaccines (Carter et al.,
2000; Kaslow, 1997; Saul, 1993, 2007), drugs (Ponsa et al., 2003;
Wells et al., 2009) or microorganisms (Boissiere et al., 2012;
Cirimotich et al., 2011a, 2011b; Dong et al., 2009; Fang et al., 2011;
Hughes et al., 2011) able to disrupt the life cycle of the parasite in
the mosquito vector, with the eventual objective of reducing both
incidence and prevalence of disease in the vertebrate host.
To assess the potency of potential TRIs, experiments compris-
ing the feeding of Anopheles mosquitoes with Plasmodium containing
blood are widely used. The “gold-standard” assay of this class is the
Membrane Feeding Assay (MFA), in which infectious blood mixed
with transmission-reducing agents is fed to mosquitoes through an
artiﬁcial membrane (Sinden, 1996). In the MFA, the number of in-
fectious parasites ingested by the mosquito from the vertebrate host
has been identiﬁed as one of the main variables that inﬂuence the
success of Plasmodium infection in the vector. Indeed, previous
studies established a positive relationship between gametocyte den-
sities and infection outcome in mosquitoes in artiﬁcial Plasmodium–
Anopheles species combinations (Dawes et al., 2009; Huff et al., 1958;
Poudel et al., 2008; Sinden et al., 2007) and in natural Plasmodium–
Anopheles systems (Boudin et al., 2004; Carter and Graves, 1988;
Drakeley et al., 1999; Gouagna et al., 1998, 1999; Huff et al., 1958;
Mulder et al., 1994; Ponnudurai et al., 1989; Robert et al., 1998).
However the precise shape of the relationship between gameto-
cyte density and subsequent infection remains largely unclear
(Churcher et al., 2013). This is unfortunate as the process of density-
dependent sporogonic development is thought to be instrumental
to the perceived success of a TRI in the MFA, and will have crucial
implications in the identiﬁcation, evaluation and comparison of new
TRI candidates (Churcher et al., 2010). A major limitation to our un-
derstanding of the effect of parasite density on infection success is
the inaccuracy in gametocyte density estimates using the stan-
dard methods of microscopy. Indeed, there is considerable sampling
variability in the numbers of gametocytes in blood, there is uncer-
tainty in the density of white-blood cells which the gametocytes
are measured against (McKenzie and Bossert, 2005; McKenzie et al.,
2005) and as high as 80% of all gametocytes might be missed during
the staining and reading procedure (Dowling and Shute, 1966). Ad-
ditionally, gametocytes vary in their maturity (Lensen et al., 1999),
sex ratio (Mitri et al., 2009; Paul et al., 2002; Reece et al., 2008), ge-
netics (Ferguson and Read, 2002; Harris et al., 2010; Lambrechts et al.,
2005) or multiplicity of infection (Nsango et al., 2012; Reece et al.,
2008) which can all inﬂuence mosquito infectivity. An additional
factor that can cause variation in assay output is the method of
sample dilution when performing the MFA. The addition of poten-
tially transmission-blocking agents to infectious blood prior to
mosquito blood meal can vary e.g. the volume and type of diluent
used to dilute can independently affect both gametocyte concen-
tration in the sample, and oocyst intensity/prevalence. The impact
of these variables needs to be fully understood to understand the
implications of assay output, particularly with regard to the com-
parison between potential TRI agents within individual MFA
experiments. To control this variation when evaluating TRI candi-
dates, a feasible method of directly comparing the ability of different
samples of blood containing gametocytes to transmit is to dilute
samples, ensuring that gametocyte numbers are directly compa-
rable between replicates.
Potential TRIs are commonly tested in the MFA with both Plas-
modium falciparum and the rodent malaria parasite, Plasmodium
berghei. The Anopheles stephensi–P. berghei species combination has
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been widely used due to its tractability and exceptional robust-
ness (Blagborough et al., 2013; Mlambo and Kumar, 2008; Ramjanee
et al., 2007; Tirawanchai et al., 1991). ‘Laboratory’ parasite–
mosquito combinations such as this allow the design of experiments
that would be technically or ethically impossible in natural species
combinations. Conversely, Anopheles–Plasmodium interactions in
natural species combinations (e.g. P. falciparum and Anopheles coluzzii)
are shaped by long term co-evolution and may differ from model
systems (Boete, 2005; Cohuet et al., 2006; Dong et al., 2006). In par-
ticular, gametocyte densities and the resulting infectivity of murine
and human Plasmodium species can differ markedly (Taylor and Read,
1997). Therefore it is imperative that results obtained in model
systems are interpreted with due regard to studies using natural
species combinations.
Understanding how vertebrate-to-mosquito transmission changes
with dilution of parasites and how this inﬂuences the perceived ef-
fectiveness of TRI in commonly used natural and model species
combinations is essential, to understand the relationship between
gametocyte density and infection outcome, to standardize current
procedures and to enhance accurate and consistent evaluation of
TRI candidates. To address this issue, natural isolates of P. falciparum
were diluted to generate a wide range of parasite densities and used
to perform experimental infections of An. coluzzii mosquitoes in con-
ditions representative of those used to measure TRI eﬃcacy in a
semi-ﬁeld context. These are compared with dilutions conducted
on P. berghei fed to An. stephensi mosquitoes in conditions repre-
sentative of those used to measure TRI eﬃcacy in the laboratory.
Additionally, using the P. berghei/An. stephensi system, the impact
of differing methods of parasite dilution on assay output was in-
vestigated. We then examined how blood dilution inﬂuenced the
observed transmission-reducing capabilities of anti-Pbs28 mono-
clonal antibody 13.1 (13.1 mAb) at a constant concentration, and
discussed the implications for the evaluation of TRIs in lab and ﬁeld
conditions.
2. Materials and methods
2.1. Experiments using the natural system:
P. falciparum–An. coluzzii
P. falciparum gametocytes were collected from naturally in-
fected volunteers recruited inmalaria endemic localities. Gametocyte
containing blood was used to infect females from a local mosquito
colony (Harris et al., 2012) of the species recently named An. coluzzii
(Coetzee et al., 2013). The protocol was approved by the Centre
MURAZ ethical review committee (003-2009/CE-CM). P. falciparum
gametocyte carriers were selected from 5 to 11 year old children
screened in villages (Soumousso and Dandé) surrounding Bobo-
Dioulasso in Burkina Faso. Gametocyte density was estimated by
microscopy read against 1000 leucocytes on thick blood smears, as-
suming a standard leukocyte count of 8000/μL. High density carriers
of P. falciparum gametocyteswere selected to generate awide range
of densities by dilution. Eligible childrenwere driven to the lab after
health examination and venous blood was collected. The gameto-
cyte densitywas re-estimated in the venous blood used formosquito
feeding. Each smearwas evaluated independently by two expertmi-
croscopists and anydiscordancewas resolved by a thirdmicroscopist
by using the mean of the two closest values.
Experimental infections of An. coluzzii female mosquitoes were
performed bymembrane feeding assays with serum replacement as
previously described (Bousema et al., 2012). Venous blood samples
were collected into heparinized tubes and were immediately cen-
trifuged at 1300 g for 3minutes. The gametocyte carrier’s plasmawas
removed and the RBC pellet mixed with serum from a European AB
blood donor. This procedure removes natural human transmission
blocking immune mechanisms, which vary between individual pa-
tients (Carter and Graves, 1988). The gametocyte density in this
substituted-serum preparation was diluted sequentially: one part of
substituted-serum blood was kept at 37 °C (infectious blood) while
the second partwas heated on a thermo-mixer at 43 °C for 15minutes
to inactivate gametocytes (non-infectious blood). Heat treatment was
previously demonstrated to fully inhibit gametocyte infectivity
(Mendes et al., 2008, 2011) withoutmeasurably affecting other blood
characteristics of mosquito ﬁtness (Sangare et al., 2013). Inactivated-
gametocyte blood was then used to dilute the infectious blood to
obtain a range of samples that contained different dilutions of in-
fectious gametocytes, yet retaining the same overall cell composition.
Blood mixtures were used to feed 24 h starved An. coluzzii females,
through pre-warmed (37 °C) membrane feeders for 30min. Fully fed
females were sorted and maintained in cages at 28 °C ± 2, 80% ± 05
RH, with 10% glucose solution available. Mosquitoes were dissect-
ed day 7 post-feeding in a drop 0.5% mercurochrome and their
midguts examined for oocysts by lightmicroscopy.When high oocyst
intensities were observed (~200 oocysts), numbers were estimated
by two microscopists; any discordance was resolved by a third mi-
croscopist by using the mean of the two closest values.
2.2. Experiments using the laboratory system:
P. berghei–An. stephensi
All procedures were performed in accordance with the terms of
the UK Animals (Scientiﬁc Procedures) Act Project Licence and were
approved by the Imperial College Ethical Review Committee (PPL
70/7185). The Oﬃce of Laboratory Animal Welfare (OLAW) Assur-
ance for Imperial College covers all Public Health Service (PHS)
supported activities involving live vertebrates in the US (#A5634-01).
General parasite maintenance was carried out as previously dis-
cussed (Sinden et al., 2002). P. berghei ANKA 2.34 parasites or
P. berghei GFP 507 cl 1 parasites, constitutively expressing GFP (Janse
et al., 2006), were maintained in 4–10 week old female Tuck Or-
dinary (TO) mice by serial mechanical passages (up to a maximum
of 8 passages). Hyper-reticulocytosis was induced 2–3 days before
infection by treating mice with 200 μL i.p. phenylhydrazinium chlo-
ride (PH; 6 mg/mL in PBS; ProLabo UK). Mice were infected by
intraperitoneal (i.p.) injection and infections were monitored on
Giemsa-stained tail-blood smears.
To assess total gametocyte numbers in individual blood samples
for MFA, following terminal anesthesia and cardiac puncture, har-
vested blood was pooled from mice and gametocytemia was
estimated by counting the percentage of erythrocytes containing
gametocytes on a Giemsa smear. Absolute gametocyte numbers were
calculated using a mean of 8,360,000 RBC/μL, which was deter-
mined by using a Neubauer hemocytometer from the used blood
samples. Pooled blood samples were stored brieﬂy at 37 °C, diluted
and used as described below.
To produce a wide range of parasite densities, mature infec-
tious P. berghei gametocytes freshly harvested from infected mice
were serially diluted to prepare samples, which were then fed to
previously starved An. stephensi mosquitoes. Within the scope of
our experiments, to examine the impact of the diluent used for
sample dilution when performing the MFA, P. berghei gameto-
cytes were diluted either 1) by dilution in naïve blood, from non-
infected, non phenylhydrazinium chloride-treated mice, freshly
harvested by cardiac puncture immediately prior to MFA; or 2) by
dilution with (gametocyte) heat-inactivated infected mouse blood
(as described in the parallel P. falciparum experiments above). Mix-
tures were prepared using the following ratios (inf/non-inf); 1:0,
3:4, 2:2, 1:4, 1:10 and 1:50.
To examine the impact of parasite dilution on TBI, pairs of serial
dilutions from the originating P. berghei infected blood were pre-
pared, one containing the anti-Pbs28 mAb 13.1, and the other
containing the non-speciﬁc IgG UPC10 (Sigma Aldrich): blood
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samples, diluted or not, were mixed with 100 μL of PBS contain-
ing mAb 13.1 or UPC10 (negative control) to give a ﬁnal antibody
concentration of 25 μg/mL. The potent transmission-blocking ability
of 13.1 has been demonstrated in numerous studies (Tirawanchai
et al., 1991; Yoshida et al., 1999), and the use of UPC10 as a isotypic
control that exhibits a total lack of non-transmission-blocking effect
has been demonstrated previously (Ramjanee et al., 2007).
Membrane feeding assays were carried out as follows; batches
of An. stephensi (SDA 500 strain) were starved for 24 hours and then
fed on 400 μL previously prepared P. berghei infected blood. In all
assays >50 fed mosquitoes were assayed per sample. 24 hours after
feeding, mosquitoes were brieﬂy anesthetized with CO2, and unfeds
were removed. Mosquitoes were then maintained on fructose [8%
(w/v) fructose, 0.05% (w/v) p-aminobenzoic acid] at 19–22 °C and
50–80% relative humidity. Day 12 post-feeding, midguts were dis-
sected from the remaining mosquitoes, and the number of oocysts
was recorded (Blagborough et al., 2013). For in vivo observation of
GFP-positive ookinetes, midguts were dissected 24 hours post-
feed. Midguts were then incubated in 4% para-formaldehyde (PFA)
for 45minutes, washed three times with PBS andmounted in a drop
of VectaShield mounting medium for ﬂuorescence with DAPI (4′,6-
diamidino-2-phenylindole), covered with a coverslip that was sealed
with nail varnish. Ookinetes were counted using a 63× objectivemag-
niﬁcation on a Leica DMR ﬂuorescence microscope.
2.3. Statistical analysis
To determine whether the impact of the dilution procedure on
oocyst prevalence and intensity was consistent across blood samples
a generalized linear mixed model was ﬁtted to the observed data
(Churcher et al., 2012). A binomial error structure was used for the
parasite presence/absence data while a zero-inﬂated negative bi-
nomial distribution was used to describe mosquito oocyst intensity.
A suite of linear models was ﬁtted to oocyst prevalence and inten-
sity estimates and the most parsimonious identiﬁed using the
likelihood ratio test. Themost simple described the number of oocyst
against gametocyte density. More complex models allowed the in-
tercept and gradient of the best ﬁt lines to vary between dilution
series. To determine whether overall there was a change in the ef-
ﬁcacy (point estimates) with gametocyte density all data were
included within a linear mixed effects model. The gradient and in-
tercept of the relationship between eﬃcacy and gametocyte density
were allowed to vary independently between dilution series. These
models were compared to a model without information on game-
tocyte density to determine whether it inﬂuenced eﬃcacy. The same
analyses were repeated with mean oocyst intensity in the control
group as the variable instead of gametocyte density.
To assess transmission-blocking activity, prevalence and inten-
sity in samples containing mAb 13.1 or UPC10 at corresponding
dilutions were compared. Treatment with mAb 13.1 was included
as the ﬁxed effect and models with or without treatment informa-
tion were compared using the likelihood ratio test to determine
whether the intervention signiﬁcantly reduced oocyst develop-
ment. To test whether there were any consistent changes in TRI
eﬃcacy within the different dilution series; the blood source was
included in these models as a random effect. Conﬁdence interval
estimates were generated by the best ﬁt model or using bootstrap-
ping methodology.
3. Results
3.1. Relationship between blood dilution and mosquito infectivity
P. falciparum gametocyte-infected blood from six naturally in-
fected volunteers was used for dilution of infectious gametocytes
and feeding of An. coluzzii females. Initial gametocyte densities
ranged from 80 to 9520 gametocytes/μL and were each used to
perform 3–5 serial dilutions. Infection outcomes were estimated by
dissecting a total of 1636 mosquitoes (mean number of dissected
midguts per experimental condition = 54.53, SD = 15.86, range: 25–
101). We observed some exceptionally high oocyst loads with, for
instance, amean of 1152 oocysts among the females fed on the blood
that contained 9520 gametocytes/μL.
Undiluted P. falciparum samplesweremore infectious than diluted
blood. The mean number of oocysts observed decreases with di-
lution in (non-infectious) heat-inactivated blood samples, as shown
by a positive correlation between estimated gametocyte density and
oocyst intensity (Fig. 1A). The relationship between gametocyte
Fig. 1. Relationship between P. falciparum gametocyte density and infection outcome in An. coluzzii. Individual colors represent sets of feeds performed from a single donor
blood sample, with gametocyte dilutions made with the same sample of heat inactivated blood. Gametocyte densities were estimated from undiluted blood samples and
subsequent densities were predicted from the dilution factor. (A) Intensity of infection; i.e. mean number of oocyst observed within the midguts post-dissection. (B) Prev-
alence of infection; i.e. percentage of infected mosquitoes. Error bars indicate 95% conﬁdence intervals.
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density and oocyst intensity appears to be adequately described by
a simple linear relationship (LL, = −6755.9). Allowing the intercept
of the line to vary between dilution series signiﬁcantly improves
the ﬁt of the model (LL = −6575.0, p value <10−8) suggesting that
factors other than just gametocyte density (as determined by mi-
croscopy) are inﬂuencing oocyst intensity. Enabling the gradient of
the line to also vary (in addition to the intercept) gives the best ﬁt
model to these data (LL = −6202.4, p value <10−8) suggesting that the
exact impact of the dilution procedure also varies between blood
samples. Correspondingly, oocyst prevalence also increases with the
concentration of infectious blood until a plateau (Fig. 1B).
In corresponding laboratory system experiments, the initial (i.e.
non diluted) gametocyte densities observed (post-bleed) ranged from
690,000 to 1,230,000 gametocytes/μL. In total, over multiple assays,
783 mosquitoes (mean number of dissected midguts per experi-
mental condition = 39.15, SD = 15.97, range: 12–60) fed on blood
samples containing potentially infectious gametocytes (either un-
diluted or diluted) and control antibodies without transmission
reducing activity (UPC10). Infection outcomes at the oocyst stage
are presented in Fig. 2. When performing the MFA with P. berghei,
diluting samples with naïve blood increases vertebrate-to-mosquito
transmission, in terms of both infection intensity and prevalence.
The mean oocyst numbers/midgut indicate a “humped” relation-
ship, with peak oocyst intensity observed at ~100,000 gametocytes/
μL, although we obtained only few data points at low gametocyte
densities (Fig. 2A). The positive relationship between gametocyte
densities and infection intensity at lower gametocyte densities is
consistent with previous studies (Sinden et al., 2007). At higher ga-
metocyte densities, a largely negative relationship between
gametocyte density and infection intensity was observed. This “di-
lution effect” can be highly signiﬁcant: for example, an average of
0.22 (95% CI [0.020; 0.431]) oocysts per midgut was observed at an
estimated gametocyte density of 1,110,000/μL, whereas an average
of 327 (95% CI [278.20; 377.00]) oocysts was observed per mos-
quito midgut when the same gametocyte containing sample was
diluted 1:10 in fresh, uninfectedmouse blood. Models which allowed
the gradient and the intercept of the best ﬁt lines to vary between
dilution series (log likelihood estimate, LL, = −3410.9) ﬁt signiﬁ-
cantly better than those which assumed that oocyst intensity was
described by gametocyte density alone (LL = −3335.4, p value < 10−8).
However, no linear model was a good ﬁt to these data indicating
that more complex functional forms will be required to capture this
relationship. In terms of prevalence, highly diluted blood samples
(with an estimated gametocyte densities between 22,500 and
100,000 gametocytes/μL) appear to infect more than 90% of the
exposed mosquitoes while feeds performed on non-diluted blood
achieve infection prevalence as low as 15%. This pattern is broadly
similar between all feeds performed (Fig. 2B). The oocyst intensi-
ties and prevalence revealed a positive relationship, in agreement
with previous observations (Churcher et al., 2012; Medley et al.,
1993).
To clarify at which life-cycle stage this “dilution effect” impacts
on transmission to the mosquito, the observed complex relation-
ship between gametocyte density and mosquito infection was
examined further. One hundred An. stephensi females were indi-
vidually fed on 5 serial dilutions of mouse blood containing P. berghei
507 cl1 GFP gametocytes, with estimated densities of 77,000–
770,000 gametocytes/μL. From feeds at each dilution, batches of 50
mosquitoes were dissected at 24 h to examine ookinete infection,
the remaining mosquitoes were examined at 13 days post infec-
tion to observe oocyst prevalence and intensity. In the dynamic range
tested a negative relationship between gametocyte density and both
ookinete density and oocyst density was observed (Fig. 3A), so that
a positive but non-linear relationship between ookinete and oocyst
numbers was also exhibited (Fig. 3B) in agreement with previous
studies (Sinden et al., 2007). This result readily suggests that the
dilution of P. berghei infected blood can improve the success of in-
fection, and this enhancement in transmission occurs at, or before
the ookinete stage of parasite development.
To further investigate the mechanisms involved in the ob-
served positive relation between dilution factor and infection success,
experiments were carried out by diluting P. berghei gametocyte in-
fected blood in parallel; either with 1) naïve, non-infected rodent
blood, or 2) by dilution with infected P. berghei mouse blood, with
gametocytes heat-inactivated (as performed in the P. falciparum ex-
periments described in previous experiments). These experiments
revealed that the nature of blood used for dilution induced con-
trasting patterns: when diluting infectious blood with naïve
uninfected blood, gametocyte density was inversely correlated to
infection success as observed in previous experiments (Fig. 2),
whereas dilutionwith heat inactivated P. berghei infected blood dem-
onstrates a positive correlation between gametocyte densities and
Fig. 2. Relationship between P. berghei gametocyte density and infection outcome in An. stephensi. Each color represents a set of feeds performed from a single originating
blood source, with subsequent gametocyte dilutions made with naïve, uninfected blood. Gametocyte densities were estimated from the undiluted blood samples and sub-
sequent densities were predicted from the dilution factor. (A) Intensity of infection; i.e. mean oocyst numbers. (B) Prevalence of infection; i.e. percentage of infected mosquitoes.
Error bars indicate 95% conﬁdence intervals. Note the log log scale in panel A which reduces the appearance of variability.
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oocyst intensity or prevalence (Fig. 4), as observed in correspond-
ing experiments with P. falciparum (Fig. 1). This clearly demonstrates
that dilution of P. berghei gametocytes with naïve uninfected blood
enhances mosquito infection, potentially as transmission-inhibiting
factors are diluted and depleted moieties are replaced. Converse-
ly, dilution of P. berghei gametocytes by blood/parasite preparations
where both cells and molecules are heat-inactivated gives rise to
a relationship where infection success is only related to the infec-
tive dose, as observed in feeds performed with P. falciparum (Fig. 1).
3.2. Infection intensity dependence of mAb 13.1 eﬃcacy
Our experiments conﬁrmed the eﬃcacy of mAb 13.1 at 25 μg/
mL. The eﬃcacy exhibited pronounced variability, depending on
expression as either reduction of oocyst intensity or prevalence, and
depending on the parasite density in ingested blood and infection
load in control groups. Measured as a reduction in mean number
of oocyst per midgut, the antibody had a mean eﬃcacy at 86.67%
(CI 83%–89%). The linear mixed effect models showed that there was
no evidence that eﬃcacy changed with gametocyte density
(p = 0.8734). (Fig. 5A). Consistently, no correlation was observed
between intensity of infection in control mosquitoes and transmis-
sion reducing activity measured as a reduction of oocyst intensity
(Fig. 5B, p = 0.2485). In contrast, considering the eﬃcacy as the re-
duction of oocyst prevalence, the antibody showed increased eﬃcacy
in less diluted P. berghei containing blood samples (Fig. 5C,
p = 0.0064), so that eﬃcacy decreases as P. berghei mean oocyst
number in control mosquitoes increases (Fig. 5D, p = 0.0161). The
negative relation between the mean number of oocysts in control
mosquito groups and the transmission blocking eﬃcacy of the an-
tibody at reducing prevalence suggests that TRI is less eﬃcient at
higher infection intensities, observed in feeds where blood samples
are diluted. The density dependant eﬃcacy of TRI is consistent with
the previously observed relationship between oocyst prevalence and
intensity based on a negative binomial distribution of oocyst
(Churcher et al., 2012): at high infection intensities, a partial trans-
Fig. 3. Mean number of ookinetes and oocysts (A) and relationship between mean number of ookinetes and mean number of oocysts (B) in An. stephensi following feeds
with diluted GFP P. berghei cl 507 gametocyte samples. Error bars indicate 95% conﬁdence intervals.
Fig. 4. Relationship between P. berghei gametocyte density and infection outcome in An. stephensi. Each color represents a set of feeds performed from a single originating
blood source, with subsequent gametocyte dilutions made with naïve non infected blood (circles), uninfected blood or heat inactivated blood (triangles). Gametocyte den-
sities were estimated from the undiluted blood samples and subsequent densities were predicted from the dilution factor. (A) Intensity of infection; i.e. mean oocyst numbers.
(B) Prevalence of infection; i.e. percentage of infected mosquitoes. Error bars indicate 95% conﬁdence intervals.
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mission reducing activity of TRIs may not affect the prevalence of
infection while the same eﬃcacy at reducing infection intensity
affects the prevalence of infectionwhen initial infection load is lower.
4. Discussion
In the natural system P. falciparum and An. coluzzii, dilutions of
gametocyte containing blood, using heat inactivated blood as diluent,
demonstrated a positive linear relationship between gametocyte
density and intensity of the infection in the mosquito for the range
of gametocyte densities observed here (estimated from 5 to 9520
gametocytes/μL). The ﬁt of the model was signiﬁcantly improved
when analyzing the dilutions series individually, with linear re-
gressions of different gradients and intercepts for each diluted blood
sample. This is indicative of a different effect of dilution for the ga-
metocyte samples obtained from distinct patients. Gametocyte
density and oocyst prevalence also revealed a positive relation until
a plateau. The differences between series of dilutions may reﬂect
numerous intrinsic characteristics of each gametocyte isolate such
as sex ratio, host response status, maturity or multiplicity of infec-
tion but also inaccuracy when assessing gametocyte density. Here,
by using dilutions of parasite isolates, we drastically reduced un-
controlled variability within dilution series and produced, to our
knowledge, the most accurate existing data for measuring the effect
of gametocyte density on mosquito infectivity in the natural
P. falciparum–An. coluzzii combination. By creating an artiﬁcial range
of gametocyte densities in a natural and epidemiologically rele-
vant Anopheles–Plasmodium system, this dilution method appears
particularly appealing for including infection intensity as a con-
trolled variable when investigating TRI evaluations. As eﬃcacy of
TRIs has been suggested to be density dependent (Churcher et al.,
2010), this will be of crucial importance for predicting the eﬃca-
cy of TRI in different and changing patterns of malaria transmission.
In this study, the plasma of the P. falciparum blood donor was
replaced by serum from a naïve donor preventing from naturally
acquired transmission reducing factors in humans. In evaluations
of candidate transmission blocking vaccines (TBV), this allows es-
timation of the eﬃcacy without presuming on the patient’s history
of exposition to parasites. Replacing the serum of the gametocyte
donor in TBV evaluation helps in the accurate primary assessment
of eﬃcacy with limited noise. However natural transmission re-
ducing immunity would interact with the TBV delivered when
Fig. 5. TRI eﬃcacy for 13.1 MAb at reducing oocyst intensity according to gametocyte density (A) or mean number of oocysts in control groups of mosquitoes (B). TRI ef-
ﬁcacy for 13.1 McAb at reducing oocyst prevalence according to gametocyte density (C) or mean number of oocysts in control groups of mosquitoes (D). Each color represents
a set of gametocyte dilutions. Vertical lines indicate 95% conﬁdence interval estimates in TBA.
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implemented in endemic areas and deserves attention. It would be
then of particular interest to investigate the eﬃcacy of naturally ac-
quired transmission reducing immunity with regard to gametocyte
density, how this will evolve in a context of malaria decline (WHO,
2011), and how this interacts with TBV eﬃcacy to better estimate
their potential eﬃcacy in ﬁeld.
Likely because we observed only comparatively high gameto-
cyte densities, and because of the serum changes performed, we
observed oocyst infection intensities that were for P. falciparum, to
our knowledge, never reported before, with the highest mean oocyst
number at approximately 1200 oocysts. Such infection intensities
are not representative of loads observed in naturally infected mos-
quitoes (Billingsley et al., 1994; Gouagna et al., 2010; Medley et al.,
1993). However it cannot be excluded that rare high infection levels
happen in nature when mosquito vectors take a blood meal on ex-
ceptionally high density gametocyte carriers. Despite these unusually
high infection intensities, prevalence was shown to plateau below
100% in laboratory infected mosquitoes. This is consistent with pre-
vious identiﬁcation of resistance alleles in natural vector populations
(Harris et al., 2010; Niare et al., 2002; Riehle et al., 2006).
P. berghei–An. stephensi is widely used as a model system for TRI
evaluation. Typically, mouse blood is used for mosquito infection
3 days post-infection in phenyl-hydrazine infectedmice; a time point
selected for its high infectivity to the vector (Dearsly et al., 1990).
For this reason, when performing gametocyte dilution in the MFA,
infectious blood was diluted with fresh, non-infected blood from
naïve mice or with heat inactivated infected blood. Dilution of
P. berghei blood containing high densities of gametocytes with fresh,
non-infected blood induced an often dramatic increase in infectiv-
ity to themosquito host. This phenomenon is reminiscent of previous
in vitro observations using rodentmalaria parasites (Janse et al., 1985;
Sinden et al., 1985), where serial dilution of P. berghei gameto-
cytes in culture dramatically enhanced ookinete production in
comparison with non-diluted controls. As far as the authors are
aware, the study is the ﬁrst time that the corresponding phenom-
enon has been investigated in vivo. Dilution with heat inactivated
infected blood conversely demonstrated a positive relation between
gametocyte density and infection load in mosquitoes, suggesting
that dilution with non-infected blood enhances infection by dilut-
ing inhibitory factors in infected blood, such as metabolites (Fleck
et al., 1994) or cytokines (Motard et al., 1993). Dilution with
uninfected blood may then have reduced the toxicity of the envi-
ronment for the remaining parasites and favored sporogony.
Alternatively, addition of fresh blood from uninfected mice could
be replenishing reduced blood moieties that aid transmission, pre-
viously exhausted by high parasitemias. From our experiments, it
cannot be excluded whether a similar phenomenon exists for
P. falciparum, although observed parasitemias are much lower in this
system than for P. berghei. In our P. falciparum experiments, human
serumwas substituted so that it cannot be determined if we removed
toxins at this step. If this is the case, it is possible that any trans-
mission reducing factors have previously mistakenly been attributed
to human immunity, although uncharacterized toxins may also be
involved. Further experiments with serum substitution in P. berghei
infected mice blood may decipher if such inhibiting factors are
present in serum alone. Additionally, it would be advantageous to
performmultiple complimentary experiments examining the impact
of antibodies, cytokines and metabolites upon the transmission of
P. falciparum, which clearly needs to be understood better than we
do at present. Recently, Pollitt et al. (2013) reported a negative re-
lationship between P. berghei oocyst and sporozoite densities at high
oocyst loads in An. stephensi. Together with our ﬁndings, this strongly
suggests that high infection densities impede parasite develop-
ment at several stages of sporogony in this species combination. The
density of the asexual parasite may also be a key component of the
density effect.
Our study was designed to investigate the relationship between
gametocyte density, intensity of oocyst infection and the eﬃcacy
of TRIs. In this speciﬁc case, the use of the P. berghei–An. stephensi
model system has highlighted a negative relationship between the
eﬃcacy of TRI and infection intensity, which may be highly rele-
vant for interventions against humanmalaria. However, interventions
which target pre-fertilization stages could potentially give mislead-
ing results when using themurinemodel if particularly high parasite
density infections are used; indeed interactions between inhibit-
ing factors and antibodies may happen and induce confounding
factors. To avoid misleading experimental conditions, investiga-
tors using P. berghei may wish to perform MFAs at a range of
gametocyte densities where gametocyte numbers and infectivity to
mosquito can be positively related.
Using an antibody directed against the P. berghei Pbs28 antigen,
we observed a constant transmission blocking activity measured as
the reduction of oocyst intensity over all infection intensities,
whereas a negative relationship between TRI eﬃcacy at reducing
prevalence and the degree of infection intensity in the control group
was found. This is consistent with previous observations where the
relationship between mean parasite load and prevalence in a mos-
quito population or sample is non-linear: at low and intermediate
loads, prevalence increases with parasite load, but at high loads, prev-
alence reaches a threshold close to 100% and is no longer affected
by parasite load. The consequence is that, at high infection levels,
a TRI may decrease the parasite load without affecting the preva-
lence (Churcher et al., 2012). These results clearly demonstrate the
need to quote both change in oocyst intensity and infection prev-
alence to allow different TRI candidates to be accurately compared
(Churcher et al., 2012). While the reduction of prevalence of infec-
tion will be relevant for predicting the eﬃcacy of the intervention
for malaria control, only the eﬃcacy at reducing the infection load
will be informative to be compared in different conditions of in-
fection intensities. Moreover, given that P. berghei–An. stephensi and
P. falciparum–An. coluzzii systems revealed a similar relationship
between mean parasite load and prevalence (Churcher et al., 2012),
we can conjecture that the density dependent TRI eﬃcacy may also
occur in the natural system P. falciparum–An. coluzzii. This de-
serves particular attention to investigate if this phenomenon occurs
in human malaria vectorial system and for all TRI candidates as it
will have major implications for their evaluations: for example, if
TRIs are evaluated in conditions where parasite load is very high
in artiﬁcially infected mosquitoes the TRI eﬃcacy on parasite prev-
alence is likely to be underestimated.
Our ﬁndings, combined with other recent studies suggest the im-
portance of infectious parasite density on the measurement of
eﬃcacy of TRI. This highlights the fact that TRI candidates must be
evaluated with regard to infection intensity. However it is surpris-
ing how little natural infection intensity in natural vectors is
documented (but see Billingsley et al., 1994; Gouagna et al., 2010;
Medley et al., 1993). This can be explained by diﬃculties in ob-
taining a large number of infected mosquitoes in nature. The few
studies that reported oocyst loads from naturally infected mosqui-
toes indicate low numbers of parasites (mean number below 5),
which is consistent with the important role of low density game-
tocyte carriage in humans (Schneider et al., 2007) for malaria
transmission. However, more accurate estimates of effective para-
site exposure in natural vector populations and subsequent infection
intensities are needed in order to evaluate TBV candidates at epi-
demiologically relevant conditions and accurately predict eﬃcacy
of interventions.
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